Holen Sie sich die Stockscreener-App
1.32
1.49%
-0.02
Handel nachbörslich:
1.32
Finanzdaten der Lyra Therapeutics Inc-Aktie (LYRA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
86.34%
0.025
|
0.183 | 0.183 | 0.209 | 0.195 |
Operating Expenses
|
30.49%
6.262
|
9.009 | 9.024 | 11.62 | 12.64 |
| Benefits Costs and Expenses |
21.16%
6.006
|
7.618 | 8.726 | 11.18 | 12.06 |
| Costs And Expenses |
21.16%
6.006
|
7.618 | 8.726 | 11.18 | 12.06 |
| Operating Income/Loss |
29.33%
-6.237
|
-8.826 | -8.841 | -11.41 | -12.44 |
| Nonoperating Income/Loss |
81.60%
0.256
|
1.391 | 0.298 | 0.435 | 0.576 |
| Income/Loss From Continuing Operations Before Tax |
19.56%
-5.981
|
-7.435 | -8.543 | -10.97 | -11.87 |
| Income Tax Expense/Benefit |
50.00%
0.003
|
0.002 | 0.004 | 0.006 | 0.007 |
| Income/Loss From Continuing Operations After Tax |
19.54%
-5.984
|
-7.437 | -8.547 | -10.98 | -11.87 |
|
Net Income/Loss
|
19.54%
-5.984
|
-7.437 | -8.547 | -10.98 | -11.87 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
31.08%
1.7678
|
1.3486 | 65.76 | 0.1326 | 65.46 |
| Diluted Average Shares |
31.08%
1.7678
|
1.3486 | 65.76 | 0.1326 | 65.46 |
| Basic Earnings Per Share |
38.66%
-3.38
|
-5.51 | -0.13 | -0.16 | -0.18 |
| Diluted Earnings Per Share |
38.66%
-3.38
|
-5.51 | -0.13 | -0.16 | -0.18 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):